Transdermal delivery by iontophoresis

Indian Journal of Pharmaceutical Sciences

Volumn 70, Issue 1, 2008, Pages 5-10

  Rawat, Swati ^a,b   Vengurlekar, Sudha ^a   Rakesh, B ^a   Jain, S ^a   Srikarti, G ^a  

^a Smriti College of Pharmaceutical Education   (India)

^b SAFE Institute of Pharmacy   (India)

Author keywords

Electro repulsion; Improved systemic bioavailability; Movement of ions; Stratum corneum

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; FENTANYL; INSULIN; KETOPROFEN; LIDOCAINE; PILOCARPINE; RETINOID DERIVATIVE; STEROID; TACRINE DERIVATIVE;

ACNE; CYSTIC FIBROSIS; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; DRUG TRANSPORT; ELECTRIC CURRENT; HUMAN; HYPERHIDROSIS; ION TRANSPORT; IONTOPHORESIS; MOLECULAR WEIGHT; OSMOSIS; PH MEASUREMENT; REVIEW; TRANSPORT KINETICS;

EID: 43449127800     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.40324     Document Type: Review

References (48)

1. Guy RH, Hadgraft J. Rate control in transdermal drug delivery. Int J Pharm 1992;82:R1-6.
2. Bouwstra JA, De Vries MA, Gooris GS, Bras W, Brussee J, Ponec M. Thermodynamic and structural aspects of the skin barrier. J Control Release 1991;15:209-20.
3. Elias PM. Epidermal barrier function: Intercellular lamellar lipid structures, origin, composition and metabolism. J Control Release 1991;15:199-208.
4. Schnetz E, Fartasch M. Microdialysis for the evaluation of penetration through the human skin barrier: A promising tool for future research. Eur J Pharm Sci 1991;12:165-74.
5. Singh J, Bahtia KS. Topical iontophoretic drug delivery, Pathways, principles, factors and skin irritation. Med Res Rev 1996;16:285-96.
6. Cullander C. What are the pathways of iontophoretic current flow through mammalian skin? Adv Drug Del Rev 1992;9:119-35.
7. Riviere JE, Heit MC. Electrically-assisted transdermal drug delivery. Pharm Res 1997;14:687-97.
8. Abramson HA, Gorin HH. Skin reactions, IX the electrophoretic demonstration of the patient pores of the living human skin, its relation to the charge of the skin. J Phys Chem 1940;44:1094-102.
9. Grimnes S. Pathways of ionic flow through human skin in vivo. Acta Derm Venereol 1984;64:93-8.
10. Burnette RR, Marrero D. Comparision between the iontophoretic and passive transport of thyrotropin releasing hormone across existed nude mouse skin. J Pharm Sci 1986;75:738-43.
11. Del Terzo S, Bhel CR, Nash RA. Iontophoretic transport of a homologues series of ionized and nonionized model compounds; Influence of Hydrophobicity and mechanistric interpretation. Pharm Res 1989;6:85-90.
12. Burettee RR, Ongipipattankul B. Characterization of the pore transport properties and tissue alteration of excised human skin during iontophoresis. J Pharm Sci 1988;77:132-7.
13. Turner NG, Guy R. Iontophoretic transport pathways, dependence on penetrant physiochemical properties. J Pharm Sci 1997;86:1385-9.
14. Deagle WR. Iontophoresis dis pain blocker, U.S. patient No. US2003100884, acc 29-5-2003.
15. Riviere JE, Sage B, Williams PL. Effects of vasoactive drugs on transdermal lidocaine iontophoresis. J Pharm Sci 1991;80:615-50.
16. Riviere JE, Monteiro NA, Inman AO. Determination of lidocaine concerntrations in skin after transdermal iontophoresis: Effects of vasoactive drugs. Pharm Res 1992;9:211-4.
17. Pikal MJ, Shah S. Transport mechanisms in iontophoresis II. Electroosmotic flow and transference number measurement for hairless mouse skin. Pharm Res 1990;7:313-21.
18. Pikal MJ. Transport mechanisms in iontophoresis, I. A theoretical model for the effect of electroosmotic flow on flux enhancement in transdermal iontophoresis. Pharm Res 1990;7:118-26.
19. Pikal MJ. The role of electroosmosic flow in transdermal iontophoresis. Adv Drug Del Rev 2001;46:281-305.
20. Uitto OD, White S. Electrosmotic pore transport in human skin. Pharm Res 2003;20:646-52.
21. Pikal MJ. The role of electroosmosic flow in transdermal iontophoresis. Adv Drug Del Rev 1992;9:201-37.
22. Inada H, Ghanem AH, Higuchi WI. Studies on the effects of applied voltage and duration on human epidermal membrane alteration/ recovery and the resultant effects upon iontophoresis. Pharm Res 1994;11:687-97.
23. Panchagula R, Pillai O, Nair VB, Ramanrao P. Transdermal iontophoresis revisited. Curr Opin Chem Boil 2000;4:468-73.
24. Marro D, Kalia YN. Delgado-Charro MB, Guy R. Contributions of electromigration and electroosmosis to iontophoretic drug delivery. Pharm Res 2001;18:1701-8.
25. Maloney JM. Local anesthesia obtained via iontophoresis as an aid to shave biopsy. Arch Dermatol 1992;128:331-3.
26. Schmidt JM, Binder M, Maicheiner W, Bielglmayer C. New treatment of atrophic acne scars by iontophoresis with estriol and tretinoin. Int J Dermatol 1995;34:53-7.
27. Sloan JB, Soltani K. Iontophoresis in dermatology. J Am Acard Dermatol 1986;5:671-84.
28. Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 1959;23:545-9.
29. Gibson LE. Iontophorestic sweat test for cyctic fibrosis, technical details. Pediatrics 1967;39:465-9.
30. Webster HL, Barlow WK. New approach to cystic fibrosis diagnosis by use of an improved sweat-induction/collection system and osmometry. Clin Chem 1981;27;385-7.
31. Panus PC, Campbell J, Kulkarni SB, Herrick R, Ravis WR, Banga AK. Transdermal iontophoretic delivery of ketoprofen through human cadaver skin and in humans. J Control Release 1997;44:113-21.
32. Ashburn MA, Streisand J, Zhang J, Love G, Rowin M, Niu S, et al. The iontophoresis of fentanyl citrate in humans. Anesthesiology 1995;82:1146-53.
33. Chein YW, Siddique O, Shi WM, Lelawongs P, Liu JC. Direct current intophoretictransdernal delivery of peptide and protein drugs. J Pharm Sci 1989;78:376-83.
34. Stepen RL, Petelenz TJ, Jacobsen SC. Potential novel methods for insulin administration: I Iontophoresis. Biomed Biochem Acta 1984;43:553-8.
35. Pillai O, Borkute SD, Sivaprasad N, Panchagnula R. Transdermal iontophoresis of insulin II: Physiochemical considerations. Int J Pharm 2003;254:271-80.
36. Pillai O, Nair V, Panchagnula R. Transdermal iontophoresis of insulin IV: Influence of chemical enhancers. Int J Pharm 2004;269:109-20.
37. Pillai O, Panchagnula R, Transdermal iontophoresis of insulin V: Efeect of terpenes. J Controlled Release 2003;88:287-96.
38. Rastogi SK, Singh J. Transepidermal transport enhancement of insulin by lipid extraction and iontophoresis. Pharm Res 2002;19:427-33.
39. Fang JY, Hung CF, Wong WW. Skin Pharmacol Physiol 2006;19:28-37.
40. Abramowitz D, Neoussikine B. Treatment by Ion Transfer, New York: Grune and Stratton; 1946. p. 87.
41. Schriber WJ, editor. A manual of electrotherapy, 4th ed., Philadelphia: Lea and Febiger; 1975. p. 125-31.
42. Bumette RR, Ongpipattanakul B. Charecterization of the pore transport properties and tissue alteration of excised human skin during iontophoresis. J Pharm Sci 1988;77:132-43.
43. Siddiqui O, Roberts MS, Polock AZ. The effect of iontophoresis and vehicle pH on the in-vitro permeation of lignocaine through human stratum corneum. J Pharm Pharmacol 1985;37:732-5.
44. Abramson HA, Alley A. Mechanisms of histamine iontophoresis from aqueous media. Arch Phys Ther 1937;18:327.
45. Chien YW, Siddiqui O, Shi W, Lelawongs P, Liu JC. Direct current iontophoretic Transdermal delivery of peptides and protein drugs. J Pharm Sci 1989;78:377.
46. Gangarosa LP, Park NH, Fong BC, Scott DF, Hill JM. Conductivity of drugs used for iontophoresis. J Pharm Sci 1978;67:1439-43.
47. Singh P, Maibach HI. Iontophoresis in drug delivery; Basic principles and applications. Crit Rev Ther Drug Car Sys 1994;11:161.
48. Available from: http://www.triz.journal.com/archives/1997/12/f/.